Seres Therapeutics, Inc. earnings per share and revenue

MCRB earnings per share for the last quarter are -0.22 USD whereas the estimation was -0.27 USD which accounts for 19.73% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of -263.83 k USD. Estimated earnings per share for the next quarter are -0.08 USD, and revenue is expected to reach 31.00 M USD. Also watch annual changes over time to get a bigger picture of MCRB earnings per share and revenue dynamics.